⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11776963 | 0.98 | — | — | |
| SCHEMBL10804336 | 0.77 | FDPS (0.38) | — | |
| SCHEMBL131287 | 0.71 | — | — | |
| SCHEMBL835617 | 0.69 | — | — | |
| SCHEMBL3499126 | 0.69 | — | — | |
| SCHEMBL835553 | 0.69 | — | — | |
| SCHEMBL1676791 | 0.67 | — | — | |
| SCHEMBL2154219 | 0.67 | — | — | |
| SCHEMBL2153675 | 0.67 | — | — | |
| SCHEMBL2153961 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408927-A1 | PROBE COMPOUND FOR DETECTING AND ISOLATING ENZYMES AND MEANS AND METHODS USING THE SAME | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2012-01-25 | — | — | EP | disclosed |
| CN-102307586-A | Compounds and methods for the treatment of autoimmune and inflammatory disease | TRINITY COLLEGE DUBLIN | 2012-01-04 | — | — | CN | disclosed |
| WO-2010105851-A1 | PROBE COMPOUND FOR DETECTING AND ISOLATING ENZYMES AND MEANS AND METHODS USING THE SAME | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-23 | — | — | WO | disclosed |
| EP-0959902-A4 | RECOMBINANT MYCOBACTERIA AUXOTROPHIC FOR DIAMINOPIMELATE | EINSTEIN COLL MED (US) | 2001-11-28 | — | — | EP | disclosed |
| US-6221364-B1 | Recombinant mycobacteria auxotrophic for diaminopimelate | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2001-04-24 | — | — | US | disclosed |
| EP-0959902-A1 | RECOMBINANT MYCOBACTERIA AUXOTROPHIC FOR DIAMINOPIMELATE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, a division of YESHIVA UNIVERSITY (US) | 1999-12-01 | — | — | EP | disclosed |
| WO-1998020898-A1 | RECOMBINANT MYCOBACTERIA AUXOTROPHIC FOR DIAMINOPIMELATE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSITY (US) | 1998-05-22 | — | — | WO | disclosed |
| US-5420347-A | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine | PFIZER INC. (US) | 1995-05-30 | — | — | US | disclosed |
| US-5371187-A | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor | PFIZER INC. (US) | 1994-12-06 | — | — | US | disclosed |
| US-5286904-A | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine | PFIZER INC. (US) | 1994-02-15 | — | — | US | disclosed |
| EP-0227306-A2 | Peptide immunostimulants | PFIZER INC. (US) | 1987-07-01 | — | — | EP | disclosed |
| US-4619915-A | ANTIINFECTION AGENTS | PFIZER INC. (US) | 1986-10-28 | — | — | US | disclosed |
| EP-0178845-A2 | Peptide-substituted heterocyclic immunostimulants | PFIZER INC. (US) | 1986-04-23 | — | — | EP | disclosed |
| US-4565653-A | Acyltripeptide immunostimulants | PFIZER INC. (US) | 1986-01-21 | — | — | US | disclosed |
| EP-0157572-A2 | Acyltripeptide immunostimulants | PFIZER INC. (US) | 1985-10-09 | — | — | EP | disclosed |
| US-4539155-A | New peptide, process for preparation thereof and use thereof | FUISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1985-09-03 | — | — | US | disclosed |
| US-4370265-A | N-ACETYLMURAMYL-L-ALANYL-D-GLUTAMIC ACID | AGENCE NATIONALE DE VALORISATION (FR) | 1983-01-25 | — | — | US | disclosed |
| US-4235771-A | ACYL-MURAMIC ACID WITH PEPTIDE CHAIN LINKED THERETO | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1980-11-25 | — | — | US | disclosed |
| EP-0011283-A1 | New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-05-28 | — | — | EP | disclosed |
| US-4186194-A | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1980-01-29 | — | — | US | disclosed |